超高龄患者心脏起搏器植入的安全性评价

Effect and safety evaluation of pacemaker implatation in extreme elderly patients

目的探讨心脏起搏器植入对90岁以上超高龄患者的疗效及安全性。方法连续入选38例首次接受起搏器治疗的超高龄患者,年龄(91.7±2.0)岁,分析其手术过程、术后并发症及术后一年随访结果。结果所有38例患者均成功植入心脏起搏器,其中单腔起搏器28例,双腔起搏器10例。1例患者因肾功能衰竭于术后24天死亡,其余患者术后无并发症,术后平均住院天数为(5.6±3.4)天。术后一年内有4例患者共5次住院,但均与起搏器无直接关联,无患者死亡,无患者出现黑矇、晕厥等症状。结论 90岁以上超高龄患者行永久心脏起搏器植入是有效且安全的。

Objective To evaluate the effect and safety of pacemaker implatation in extreme elderly patients over 90 years old, Methods Totally 38 patients over 90 years old who received first implantation of permanent pace- makers were enrolled. The average age was （91.7±2.0） years old. Operation process, complications and the results / of follow-up were analyzed. Results All patients succeeded in pacemaker implanting. Single-chamber pacemakers were used in 28 patients and double-chamber pacemakers in 10 patients. One case died after operation because of se- rious renal failure. Other patients survived till 1-year follow-up. No complications such as capsular hematoma and in- fection happened during operation and 1-year follow-up. Four patients were hospitalized five times hut the reasons for hospitalization were not significantly associated with pacemaker implatation. No patients suffered from amaurosis or syncope during the follow-up. Conclusion Pacemaker implatation in extreme elderly patients over 90 years old is effective and safe.